Clinical Trial Update: Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating therapeutic efficacy and safety of umbilical mesenchymal stem cells (UMSCs) for retinitis pigmentosa.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• UMSCs (umbilical mesenchymal stem cells)

Snippet

Sponsor: Jinnah Burn and Reconstructive Surgery Centre, Lahore | Conditions: Retinitis Pigmentosa (RP) | Phase 2 | Status: UNKNOWN